Androgen Dependence of Hirsutism, Acne, and Alopecia in Women

Abstract

Hirsutism, acne, alopecia, and oligo-amenorrhea are clinical expressions of hyperandrogenism, one of the most frequent endocrine disorders in women of reproductive age. Women referred to our endocrine clinics for skin symptoms of hyperandrogenism underwent a laboratory workup to evaluate hormone measurements and received antiandrogen therapy. We retrospectively analyzed the outcome of 228 consecutive patients investigated over 6 years.Patients with hirsutism had higher levels of androstenedione, dehydroepiandrosterone sulfate (DHEAS), and salivary testosterone; lower levels of sex hormone-binding globulin (SHBG); and a higher prevalence of oligo-amenorrhea than patients with alopecia, while patients with acne showed intermediate values. Hirsutism score correlated positively with androstenedione, DHEAS, and salivary testosterone, and correlated negatively with SHBG; salivary testosterone showed the highest correlation coefficient. Total testosterone was not significantly different among patients with hirsutism, alopecia, or acne, and did not significantly correlate with hirsutism score. Hirsutism and oligo-amenorrhea were the most sensitive symptoms of hyperandrogenism, and no androgenic parameter alone allowed us to identify all cases of hyperandrogenism.Patients of central European origin sought consultation with milder hirsutism scores than patients of southern European origin. There was, however, no difference in the clinical-biological correlation between these groups, arguing against differences in skin sensitivity to androgens.Polycystic ovary syndrome, defined as hyperandrogenism (hirsutism or elevated androgens) and oligo-amenorrhea, was diagnosed in 63 patients (27.6%), an underestimate compared with other reports that include systematic ovarian ultrasound studies. Neither pelvic ultrasound, used in a limited number of cases, nor the luteinizing hormone/follicle-stimulating hormone ratio helped to distinguish patients with polycystic ovary syndrome from the other diagnostic groups. These included hyperandrogenism (hirsutism or elevated androgens) and eumenorrhea (101 patients; 44.3%); normal androgens (acne or alopecia and eumenorrhea) (51 patients; 22.4%); isolated low SHBG (7 patients; 3.1%); nonclassical congenital adrenal hyperplasia (4 patients; 1.8% of total, 4.9% of patients undergoing cosyntropin stimulation tests); and ovarian tumor (2 patients; 0.9%).Ethinylestradiol and high-dose cyproterone acetate treatment lowered the hirsutism score to 53.5% of baseline at 1 year, and was also effective in treating acne and alopecia. The clinical benefit is ascribed to the peripheral antiandrogenic effect of cyproterone acetate as well as the hormone-suppressive effect of this combination. Salivary testosterone showed the most marked proportional decrease of all the androgens under treatment. Cost-effectiveness and tolerance of ethinylestradiol and high-dose cyproterone acetate compared well with other antiandrogenic drug therapies for hirsutism. The less potent therapy with spironolactone only, a peripher...

Prevalence of Acne Vulgaris in Patients with Down Syndrome

“…The missing correlation of obesity, metabolic disorders and hyperandrogenemia and acne found in our study disputes the concept of an involvement of a high-caloric diet in the etiopathogenesis of acne at least in DS patients. These findings corroborate the fact that hyperandrogenemia is uncommon in adolescent and adult women even with severe acne [9,10,35] and support the concept of an association of hyperandrogenism (enhanced sensitivity of the sebaceous gland to normal circulating androgen levels) and acne [1,2,8]. …”

“…However, no association of obesity with acne could be observed in our DS patients. Moreover, acne tarda in females has been associated with obesity and hyperandrogenism due to SAHA or hyperandrogenemia mainly caused by polycystic ovary syndrome [8,33,35,36]. In addition, a possible role of a high-caloric diet in the etiopathogenesis of acne, particularly in subjects tending to obesity and insulin resistance, has been widely discussed [3,6,37,38,39].…”

Revising the role of the androgen receptor in breast cancer

“…In women, antiandrogens are currently administered to treat various medical conditions attributed to aberrations in the androgen pathway (e.g. amenorrhoea, androgenic alopecia and hirsutism), and they have also been trialled for the treatment of ovarian cancer (reviewed in Karrer-Voegeli et al (2009) and Papadatos-Pastos et al (2011)). Similarly, the AR is also now considered as a therapeutic target for the treatment of BC, with methods to activate the receptor as a potential option for ERa-positive disease, and inhibition of the receptor as an option for molecular apocrine disease.…”

Androgenic Hormone Profile of Adult Women with Acne

“…Acne cases are frequently followed by menstrual irregularity, hirsutism or hypertrichosis, recidivism of seborrheic dermatitis, obesity or waist circumference increase and female androgenetic alopecia [12,13]. …”